Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1041
| Despition | Recombinant Human Wnt3a Protein for SDS-PAGE |
| SIZE | 50 µg |
| Source | Recombinant |
| Protein Length | Fragment |
| Expression System | HEK293 cells |
| Protein Species | Human |
| Molecular Weight | 105.9 kDa |
| Purity | > 90% by SDS-PAGE under reducing conditions |
| Form | Lyophilized |
| Applications | SDS-PAGE |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1093 | Synthetic Nanodisc Human CCR5 Protein (AC1093) | 10 µg | inquiry |
| ACPP-1368 | KCNJ2 Blocking Peptide (AC1368) | 250 µg | inquiry |
| ACPP-1692 | Human GLUL Protein (AC1692) | 5 µg | inquiry |
| ACPP-1610 | Mouse MANF Protein (AC1610) | 5 µg | inquiry |
| ACPP-1291 | FGFR1 Blocking Peptide (AC1291) | 250 µg | inquiry |
| ACPP-1092 | Synthetic Nanodisc Human GLP-1R Protein (AC1092) | 10 µg | inquiry |
| ACPP-1683 | Human RCAN2 Protein (AC1683) | 5 µg | inquiry |
| ACPP-1517 | Human PGRN Protein (AC1517) | 2 µg | inquiry |
| ACPP-1293 | TORC2 Blocking Peptide (AC1293) | 250 µg | inquiry |
| ACPP-1839 | Human Ornithine Aminotransferase Protein (AC1839) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.